Fiorillo Maria Teresa, Rückert Christine, Hülsmeyer Martin, Sorrentino Rosa, Saenger Wolfram, Ziegler Andreas, Uchanska-Ziegler Barbara
Dipartimento di Biologia Cellulare e dello Sviluppo, Università di Roma La Sapienza, via dei Sardi 70, 00185 Roma, Italy.
J Biol Chem. 2005 Jan 28;280(4):2962-71. doi: 10.1074/jbc.M410807200. Epub 2004 Nov 10.
Molecular mimicry is discussed as a possible mechanism that may contribute to the development of autoimmune diseases. It could also be involved in the differential association of the human major histocompatibility subtypes HLA-B()2705 and HLA-B()2709 with ankylosing spondylitis. These two subtypes differ only in residue 116 of the heavy chain (Asp in B()2705 and His in B()2709), but the reason for the differential disease association is not understood. Using x-ray crystallography, we show here that the viral peptide pLMP2 (RRRWRRLTV, derived from latent membrane protein 2 (residues 236-244) of Epstein-Barr virus) is presented by the B()2705 and B()2709 molecules in two drastically deviating conformations. Extensive structural similarity between pLMP2 and the self-peptide pVIPR (RRKWRRWHL, derived from vasoactive intestinal peptide type 1 receptor (residues 400-408)) is observed only when the peptides are presented by B(*)2705 because of a salt bridge between Arg(5) of both peptides and the subtype-specific heavy chain residue Asp(116). Combined with functional studies using pLMP2/pVIPR-cross-reactive cytotoxic T cell lines and clones, together with target cells presenting these peptides or a modified peptide analogue, our results reveal that a pathogen-derived peptide can exhibit major histocompatibility complex class I subtype-dependent, drastically distinct binding modes. Furthermore, the results demonstrate that molecular mimicry between pLMP2 and pVIPR in the HLA-B27 context is an allele-dependent property.
分子模拟被认为是一种可能导致自身免疫性疾病发展的机制。它也可能参与人类主要组织相容性亚型HLA - B()2705和HLA - B()2709与强直性脊柱炎的差异关联。这两种亚型仅在重链的第116位残基上有所不同(B()2705为天冬氨酸,B()2709为组氨酸),但疾病差异关联的原因尚不清楚。通过X射线晶体学,我们在此表明,病毒肽pLMP2(RRRWRRLTV,源自爱泼斯坦 - 巴尔病毒的潜伏膜蛋白2(残基236 - 244))由B()2705和B()2709分子以两种截然不同的构象呈递。仅当肽由B(*)2705呈递时,才观察到pLMP2与自身肽pVIPR(RRKWRRWHL,源自1型血管活性肠肽受体(残基400 - 408))之间存在广泛的结构相似性,这是由于两种肽的精氨酸(5)与亚型特异性重链残基天冬氨酸(116)之间形成了盐桥。结合使用pLMP2/pVIPR交叉反应性细胞毒性T细胞系和克隆以及呈递这些肽或修饰肽类似物的靶细胞进行的功能研究,我们的结果表明,病原体衍生的肽可以表现出主要组织相容性复合体I类亚型依赖性、截然不同的结合模式。此外,结果表明在HLA - B27背景下pLMP2和pVIPR之间的分子模拟是一种等位基因依赖性特性。